Validated using a knockout cell line
Recombinant
RabMAb

Recombinant Anti-CD13 antibody [EPR4058] (ab108310)

Knockout Tested Rabbit recombinant monoclonal CD13 antibody [EPR4058]. Validated in WB, IP, IHC, ICC/IF and tested in Mouse, Rat, Human. Cited in 5 publication(s). Independently reviewed in 5 review(s).

Publishing research using ab108310? Please let us know so that we can cite the reference in this datasheet.

ab108310 has been referenced in 6 publications.

  • Shui LJ  et al. Aminopeptidase N expression in the endometrium could affect endometrial receptivity. Biochem Biophys Res Commun 514:469-474 (2019). PubMed: 31056265
  • Harada K  et al. Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors. BMC Cancer 16:548 (2016). PubMed: 27464948
  • Nefla M  et al. The pro-inflammatory cytokine 14-3-3e is a ligand of CD13 in cartilage. J Cell Sci 128:3250-62 (2015). IHC . PubMed: 26208633
  • Vaswani K  et al. The rat placental renin-angiotensin system - a gestational gene expression study. Reprod Biol Endocrinol 13:89 (2015). WB, IHC . PubMed: 26260700
  • Cui SX  et al. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13). Eur J Pharmacol 734:50-9 (2014). PubMed: 24726845
  • Härdtner C  et al. High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic ß-cells. Int J Mol Med 32:795-804 (2013). WB ; Rat . PubMed: 23942780

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up